Cleared Traditional

K254167 - MDx-Chex for BCY (FDA 510(k) Clearance)

Mar 2026
Decision
84d
Days
Class 2
Risk

K254167 is an FDA 510(k) clearance for the MDx-Chex for BCY. This device is classified as a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II - Special Controls, product code PMN).

Submitted by Streck, LLC (La Vista, US). The FDA issued a Cleared decision on March 17, 2026, 84 days after receiving the submission on December 23, 2025.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3920. Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use..

Submission Details

510(k) Number K254167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2025
Decision Date March 17, 2026
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PMN — Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3920
Definition Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use.